- R&D
Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...Takeda Pulls Application For Dengue Vaccine Qdenga
Travelers and medical professionals from the U.S. who are hoping for a different, maybe safer, dengue vaccination will have to wait.Novartis drug helps stop breast cancer’s return in a large study
According to clinical study findings, when administered following surgery in adults at risk of recurrence, a Novartis-targeted medicine lowered the chance of...
- Clinical
Novocure’s TTFields Misses the Mark in Phase 3 Ovarian Cancer Trial
In a striking departure from earlier this year's promising findings, Novocure's groundbreaking technology known as Tumor Treating Fields (TTFields) has encountered a...BridgeBio Explores Phase 3 Acoramidis Data in Depth
BridgeBio is delving deeper into the phase 3 research of acoramidis, focusing on individuals suffering from transthyretin amyloid cardiomyopathy (also known as...Roche posts encouraging interim study results for a lung cancer treatment
Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlight when positive data from an interim analysis of a lung cancer...Pfizer Slashes Enrollment For Lyme Disease Trial Following CRO Trouble
Due to issues that arose with the CRO responsible for developing Pfizer's Lyme disease vaccine, the head of vaccine R&D, Annaliesa Anderson,...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
Bayer Banks on Kerendia’s Potential in Heart Failure Space
Kerendia (finerenone), manufactured by Bayer and approved two summers ago for the treatment of chronic kidney disease (CKD) linked with type 2...Beta Bionics Secures $100 Million for Artificial Pancreas Expansion Following FDA Approval
Beta Bionics, a Massachusetts-based company, has garnered a substantial infusion of funding amounting to $100 million after securing approval from the U.S....Rite Aid to file for bankruptcy to reorganize debt and stop ongoing drug litigation
Rite Aid is reportedly on the brink of initiating a bankruptcy filing within the upcoming weeks as part of its strategy to...
- Technology
Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...FDA Approves Terumo’s Reveos System: Automated Whole Blood Processing to Address Platelet Shortage
Terumo Blood and Cell Technologies have introduced the Reveos system, an automated blood-processing machine designed to separate platelets and other components from...
- Regulatory
European Commission Approves Updated Pfizer-BioNTech Vaccine for Omicron XBB.1.5 Variant
The European Commission has recently achieved a significant milestone in the ongoing battle against COVID-19 in preparation for the upcoming autumn and...NICE gives Chiesi’s Elfabrio go ahead
Chiesi has recently garnered a favorable recommendation from the National Institute for Health and Care Excellence (NICE) in relation to their cutting-edge...Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta
AbbVie, a prominent player in the pharmaceutical industry, has recently achieved a significant milestone by securing marketing authorization for its groundbreaking migraine...Bristol Myers Secures Crucial FDA Approval for Treatment of Bone Marrow Disease
In a strategic move to counteract the impending patent challenges for some of its top-selling medications, Bristol Myers Squibb has achieved a...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...Takeda Pulls Application For Dengue Vaccine Qdenga
Travelers and medical professionals from the U.S. who are hoping for a different, maybe safer, dengue vaccination will have to wait.Novartis drug helps stop breast cancer’s return in a large study
According to clinical study findings, when administered following surgery in adults at risk of recurrence, a Novartis-targeted medicine lowered the chance of...
- Clinical
Novocure’s TTFields Misses the Mark in Phase 3 Ovarian Cancer Trial
In a striking departure from earlier this year's promising findings, Novocure's groundbreaking technology known as Tumor Treating Fields (TTFields) has encountered a...BridgeBio Explores Phase 3 Acoramidis Data in Depth
BridgeBio is delving deeper into the phase 3 research of acoramidis, focusing on individuals suffering from transthyretin amyloid cardiomyopathy (also known as...Roche posts encouraging interim study results for a lung cancer treatment
Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlight when positive data from an interim analysis of a lung cancer...Pfizer Slashes Enrollment For Lyme Disease Trial Following CRO Trouble
Due to issues that arose with the CRO responsible for developing Pfizer's Lyme disease vaccine, the head of vaccine R&D, Annaliesa Anderson,...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
Bayer Banks on Kerendia’s Potential in Heart Failure Space
Kerendia (finerenone), manufactured by Bayer and approved two summers ago for the treatment of chronic kidney disease (CKD) linked with type 2...Beta Bionics Secures $100 Million for Artificial Pancreas Expansion Following FDA Approval
Beta Bionics, a Massachusetts-based company, has garnered a substantial infusion of funding amounting to $100 million after securing approval from the U.S....Rite Aid to file for bankruptcy to reorganize debt and stop ongoing drug litigation
Rite Aid is reportedly on the brink of initiating a bankruptcy filing within the upcoming weeks as part of its strategy to...
- Technology
Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...FDA Approves Terumo’s Reveos System: Automated Whole Blood Processing to Address Platelet Shortage
Terumo Blood and Cell Technologies have introduced the Reveos system, an automated blood-processing machine designed to separate platelets and other components from...
- Regulatory
European Commission Approves Updated Pfizer-BioNTech Vaccine for Omicron XBB.1.5 Variant
The European Commission has recently achieved a significant milestone in the ongoing battle against COVID-19 in preparation for the upcoming autumn and...NICE gives Chiesi’s Elfabrio go ahead
Chiesi has recently garnered a favorable recommendation from the National Institute for Health and Care Excellence (NICE) in relation to their cutting-edge...Marketing Authorization Granted for AbbVie’s Migraine Therapy Aquipta
AbbVie, a prominent player in the pharmaceutical industry, has recently achieved a significant milestone by securing marketing authorization for its groundbreaking migraine...Bristol Myers Secures Crucial FDA Approval for Treatment of Bone Marrow Disease
In a strategic move to counteract the impending patent challenges for some of its top-selling medications, Bristol Myers Squibb has achieved a...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
J&J Files For Approval of Carvykti in Europe
Johnson & Johnson has reached another milestone in their competition with Bristol-Myers...
Mekonos closes $25M funding round for cell therapy platform
Mekonos closes funding of $25M in a series a round as it...
Alphabet’s health subsidiary Verily cuts staff by 15% in a bid to strategize and reorganize
In an email shared with Verily employees recently, the company CEO Stephen...
Must Read
Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the...
European Commission Approves Updated Pfizer-BioNTech Vaccine for Omicron XBB.1.5 Variant
The European Commission has recently achieved a significant milestone in the ongoing...
NICE gives Chiesi’s Elfabrio go ahead
Chiesi has recently garnered a favorable recommendation from the National Institute for...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com